NF-κB DNA-binding activity in embryos responding to a teratogen,cyclophosphamide

BMC Developmental Biology

Volumn 2, Issue , 2002, Pages 1-11

  Torchinsky, Arkady ^a   Lishanski, Lucy ^a   Wolstein, Orit ^b   Shepshelovich, Jeanne ^a   Orenstein, Hasida ^a   Savion, Shoshana ^a   Zaslavsky, Zeev ^a   Carp, Howard ^a   Brill, Alexander ^a   Dikstein, Rivka ^b   Toder, Vladimir ^a   Fein, Amos ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CYCLOPHOSPHAMIDE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLATE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN LEVEL; BRAIN MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DOSE RESPONSE; DRUG POTENTIATION; DRUG SENSITIVITY; EMBRYO; EMBRYOPATHY; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIVER DISEASE; LIVER LEVEL; MOUSE; NONHUMAN; PROTEIN DNA BINDING; TERATOGENESIS; TERATOLOGY;

ANIMALIA;

EID: 34248368065     PISSN: 1471213X     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-213X-2-2     Document Type: Article

References (47)

1. Jacobson MD, Weil M, Raff MC: Programmed cell death in animal development. Cell 1997, 88:347-354
2. Sadler TW, Hunter ES III: Principles of abnormal development. Past, present and future. In: Developmental Toxicology 199453-63
3. Knudsen TB: Cell death. In: Drug Toxicity in Embryonic Development I 1997211-244
4. Green DR: Apoptotic pathways: the roads to ruin. Cell 1998, 94:695-698
5. M. Barkett, Gilmore TD: Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6910-6924
6. Aggarwal BB: Apoptosis and nuclear factor-kappaB: a tale of association and dissociation. Biochem Pharmacol 2000, 6:1033-1039
7. Liou HC, Baltimore D: Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr Opin Cell Biol 1993, 3:477-487
8. Schmitz ML, Baeuerle PA: Multi-step activation of NF-kappa B/Rel transcription factors. Immunobiology 1995, 193:116-127
9. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 1995, 9:2723-2735
10. Pahl HL: Activators and target genes of Rel/NF-kB transcription factors. Oncogene 1999, 18:6853-6866
11. Kami M: Minireview. The beginning of the end: IkB kinase (IKK) and NF-kB activation. J Biol Chem 1999, 274:27339-27342
12. Chen FE, Ghosh G: Regulation of DNA binding by Rel/NF-κB transcription factors: structural views. Oncogene 1999, 18:6845-6852
13. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376:167-170
14. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Jonson R, Kami M: The IKKp subunit of ikb kinase (IKK) is essential for Nuclear Factor kb activation and prevention of apoptosis. J Exp Med 1999, 189:1839-1845
15. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM: Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999, 284:321-325
16. Dot TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y: Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 1999, 96:2994-2999
17. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, Goeddel DV: Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999, 10:421-429
18. Rosenfeld ME, Prichard L, Shiojiri N, Fausto N: Prevention of hepatic apoptosis and embryonic lethality in RelA/TNFR-1 double knockout mice. Am J Pathol 2000, 56:997-1007
19. Chen B, Cyr DG, Hales BF: Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro. Teratology 1994, 50:1-12
20. Torchinsky A, Savion S, Gorivodsky M, Shepsheiovich J, Zaslavsky Z, Fein A, Toder V: Cyclophosphamide-induced teratogenesis in ICR mice: The role of apoptosis. Teratogen Carcinogen Mutagen 1995, 15:179-190
21. Torchinsky A, Ivnitsky I, Savion S, Shepshelovich J, Gorivodsky M, Fein A, Carp H, Schwartz D, Frankel J, Rotter V, Toder V: Cellular events and the pattern of p53 protein expression following cyclophosphamide-initiated cell death in various organs of developing embryo. Teratog Carcinog Mutagen. 1999, 19:353-367
22. Slee EA, Adrain C, Martin SJ: Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 1999, 6:1067-1074
23. Nicholson DW: Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 1999, 6: 1028-1042
24. Mirkes PE: Cyclophosphamide teratogenesis: a review. Teratogen Carcinogen Mutagen 1985, 5:75-88
25. Chernoff NJ, Rogers M, Alles AJ, Zucker RM, Elstein KH, Massaro EJ, Sulik KK: Cell cycle alterations and cell death in cyclophosphamide teratogenesis. Teratogen Carcinogen Mutagen 1989, 9:199-209
26. Francis BM, Rogers JM, Sulik KK, Alles AJ, Elstein KH, Zucker RM, Massaro EJ, Rosen MB, Chernoff N: Cyclophosphamide teratogenesis: Evidence for compensatory responses to induced cellular toxicity. Teratology 1990, 42:473-482
27. Mirkes PE, Little SA: Teratogen-induced cell death in postimplantation mouse embryos: differential tissue sensitivity and hallmarks of apoptosis. Cell Death Differ 1998, 5:592-600
28. Kopp E, Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994, 265:956-959
29. Frantz B, O'Neill EA: The effect of sodium salicylate and aspirin on NF-kappa B. Science 1995, 270:2017-2019
30. Yin MJ, Yamamoto Y, Gaynor RB: The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature 1998, 396:77-80
31. Schreiber E, Matthias P, Müller MM, Schaffner W: Rapid detection of octamer binding-proteins with mini-extracts, prepared from a small number of cells. Nuc Acid Res 1989, 17:6419
32. Sokal RR, Rohlf FJ: Biometry, New York, Freeman and Company 1995
33. Torchinsky A, Fein A, Toder V: Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice. Am J Reprod Immunol 1995, 34:288-298
34. Schmidt-Ullrich R, Memet S, Lilienbaum A, Feuillard J, Raphael M, Israel A: NF-kappaB activity in transgenic mice: developmental regulation and tissue specificity. Development 1996, 122:2117-2128
35. Gerondakis S, Grossmann M, Nakamura Y, Pohl T, Grumont R: Genetic approaches in mice to understand Rel/NF-kappaB and IkappaB function: transgenics and knockouts. Oncogene 1999, 18:6888-6895
36. Diehl AM: Effect of ethanol on tumor necrosis factor signaling during liver regeneration. Clin Biochem 1999, 32:571-578
37. Plumpe J, Maiek NP, Bock CT, Rakemann TMP, Trautwein C: NF-kappaB determines between apoptosis and proliferation in hepatocytes during liver regeneration. Am J Physiol Gastrointest Liver Physiol 2000, 278:G173-183
38. Schwenger P, Skolnik EY, Vilcek J: Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate. J Biol Chem 1996, 271:8089-8094
39. Schwenger P, Bellosta P, Vietor I, Basilico C, Skolnik EY, Vilcek J: Sodium salicylate induces apoptosis via p38 mitogen-activated protein kinase but inhibits tumor necrosis factor-induced c-Jun N-terminal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci USA 1997, 94:2869-2873
40. Dong Z, Huang C, Brown RE, Ma WY: Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J Biol Chem 1997, 272:9962-9970
41. Alessandrini A, Brott BK, Erikson RL: Differential expression of MEK1 and MEK2 during mouse development. Cell Growth Differ 1997, 8:505-511
42. Lee JK, Hwang WS, Lee YD, Han PL: Dynamic expression of SEK1 suggests multiple roles of the gene during embryogenesis and in adult brain of mice. Mol Brain Res 1999, 66:133-140
43. Mirkes PE, Wilson KL, Cornel LM: Teratogen-induced activation of ERK, JNK, and p38 MAP kinases in early postimplantation murine embryos. Teratology 2000, 62:14-25
44. Horton ND, Biswal SS, Corrigan LL, Bratta J, Kehrer JP: Acrolein causes inhibitor KB-independent decreases in nuclear factor kb activation in human lung adenocarcinoma (A546) cells. J Biol Chem 1999, 274:9200-9206
45. Li L, Hamilton RF Jr, Holian A: Effect of acrolein on human alveolar macrophage NF-κB activity. Am J Physiol 1999, 277:L550-L557
46. Mayo MW, Baldwin AS: The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 2000, 1470:M55-62
47. Sheikh MS, Fornace AJ Jr: Death and decoy receptors and p53-mediated apoptosis. Leukemia 2000, 14:1509-1513